** Wellnex Life WNX.AX rises 6.3% to A$0.17, highest since December 9
** Consumer healthcare business sees H2 FY26 EBITDA improving by A$2.4 million ($1.6 million) vs prior comparative period
** Adds December EBITDA rose A$0.7 million vs last year, helped by lower operating costs
** WNX tanked 84.3% last year
($1 = A$1.4921)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.